Yan Fu
22Patents
4h-index
44Co-inventors
59Inventor score
Filing activity: Dec 8, 2000 → Feb 26, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10119133B2 | Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing | Chemistry; Metallurgy | 39 | Active |
| US7244833B2 | Recombinant human albumin fusion proteins with long-lasting biological effects | Emerging Cross-Sectional Technologies | 28 | Expired |
| US7442371B2 | Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects | Emerging Cross-Sectional Technologies | 19 | Active |
| US8084021B2 | Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects | Emerging Cross-Sectional Technologies | 19 | Active |
| US8603973B2 | Skincare composition comprising HSA fusion protein, preparation method and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US7572437B2 | Long acting human interferon analogs | Emerging Cross-Sectional Technologies | 2 | Active |
| US8796285B2 | Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof | Human Necessities | 2 | Active |
| US9114094B2 | Method of use and preparation of HSA fusion protein composition for skincare | Chemistry; Metallurgy | 2 | Active |
| US9145452B2 | Application of fibrinogen-420 and its active domain | Human Necessities | 0 | Active |
| US10054590B2 | Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy | Physics | 0 | Active |
| US8975030B2 | Method for cancer detection | Emerging Cross-Sectional Technologies | 0 | Active |
| US7056672B2 | Method of identifying an open reading frame using a nucleic acid molecule encoding multiple start codons and histidine tags | Chemistry; Metallurgy | 0 | Expired |
| US10106506B2 | General process for the preparation of 6-substituted or 5,6-disubstituted derivatives of 2-amino-isonicotinic acid | Chemistry; Metallurgy | 0 | Active |
| US10131618B2 | Process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dione | Chemistry; Metallurgy | 0 | Active |
| US10647968B2 | Endostatin mutants with mutations at ATP binding sites | Emerging Cross-Sectional Technologies | 0 | Active |
| US9938228B2 | Process for the preparation of spiro[2.5]octane-5,7-dione and spiro[3.5]nonane-6,8-dione | Chemistry; Metallurgy | 0 | Active |
| US9637454B2 | Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9364493B2 | Methods and compositions for enhancing the uptake of therapeutic agents by target cells | Human Necessities | 0 | Active |
| US8389684B2 | Tumor biomarker | Emerging Cross-Sectional Technologies | 0 | Active |
| US6709863B2 | Nucleic acid molecules encoding multiple start codons and histidine tags | Chemistry; Metallurgy | 0 | Expired |
| US6428961B1 | Nucleic acid molecules encoding histidine tags in three reading frames | Chemistry; Metallurgy | 0 | Expired |
| US9815906B2 | Method of inhibiting or treating cancer metastasis | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.